secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sarepta Therapeutics, Inc. (SRPT)
CIK:        0000873303
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001193125-24-157458
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sarepta increases incentive plan shares by 500,000; all director nominees elected at annual meeting
--------------------------------------------------------------------------------

- Board approved amendment to 2024 Employment Commencement Incentive Plan, increasing share reserve by 500,000 to 6,185,308 shares.
- At June 6 annual meeting, all four Class I director nominees (Douglas Ingram, Hans Wigzell, Kathryn Boor, Michael Chambers) were elected.
- Advisory say-on-pay proposal passed with approximately 63.6 million votes for and 9.0 million against.
- Stockholders ratified KPMG as independent auditor for 2024; approximately 77.1 million votes in favor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/873303/000119312524157458/0001193125-24-157458-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/873303/000119312524157458/d810236d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-157458

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer